Please login to the form below

Not currently logged in
Email:
Password:

Zavicefta

This page shows the latest Zavicefta news and features for those working in and with pharma, biotech and healthcare.

Merck preps regulatory filings for much-needed antibiotic combo

Merck preps regulatory filings for much-needed antibiotic combo

It’s been sold in Europe by Pfizer as Zavicefta since 2016.

Latest news

  • Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

    The antibiotic is sold in Europe by Pfizer under the Zavicefta brand name and got a green light from the EMA in 2016. ... Zavicefta is already approved in Europe for HABP/VABP. One of the key roles for the new product is in the treatment of infections

  • Pfizer launches antibiotic resistance surveillance website Pfizer launches antibiotic resistance surveillance website

    Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn

  • Pfizer launches new antibiotic Zavicefta in UK and Germany Pfizer launches new antibiotic Zavicefta in UK and Germany

    The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of complicated Gram-negative bacterial infections requiring hospitalisation last year. ... The availability of Zavicefta is a major step forward for

  • AZ slims down again with sale of antibiotics to Pfizer AZ slims down again with sale of antibiotics to Pfizer

    The deal includes the approved antibiotics Merrem (meropenem), Zinforo (ceftaroline fosamil) and just-licensed Zavicefta (ceftazidime/avibactam), as well as two injectable antibiotic candidates - Allergan-partnered ATM-AVI (aztreonam/avibactam) and

  • AZ gets EU green light for new antibiotic Zavicefta AZ gets EU green light for new antibiotic Zavicefta

    EMA approves combination drug for treatment of multidrug resistant infections. AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in the EU. ... The European Medicines Agency (EMA) cleared

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics